Premaligne lidelser i cervix uteri
Vedlegg A
Sist oppdatert: 16.12.2025
Mer informasjon
Utgiver: Helsedirektoratet
Versjon: 1.0
Tidligere versjoner
Foreslå endringer/gi kommentarer
Swede kolposkopi score
|
Poeng |
0 |
1 |
2 |
|---|---|---|---|
|
Aceto opptak |
0 eller transparent |
Slørete |
Stearinflekk |
|
Kanter |
0 eller diffuse |
Uregelmessige, flikete, skarpe. Satelitter |
Regelmessige, skarpe eller nivåforskjell |
|
Kapillær mønster |
Fint, regelmessig |
Savnet |
Grove eller bisarre kar |
|
Størrelse |
< 5 mm |
5–15 mm eller 2 kvadranter |
> 15 mm, 3–4 kvadranter eller endocervikalt uavgrensbart |
|
Jod-opptak |
Brunt |
Svakt gult eller flekkete |
Kanarigult |
Referanser
Folkehelseinstituttet (02. jan 2020).
Nasjonal oppfølging av vaksinasjons-programmet for HPV. [nettdokument]. Oslo: Folkehelseinstituttet. Hentet 21. jan 2020 fra
https://www.fhi.no/studier/hpv-oppfolging/
Folkehelseinstituttet (21. mai 2019).
Statistikk for HPV-vaksinasjon i barnevaksinasjonsprogrammet. [nettdokument]. Oslo: Folkehelseinstituttet. Hentet 21. jan 2020 fra
https://www.fhi.no/hn/helseregistre-og-registre/sysvak/dekkningsstatistikk/
Folkehelseinstituttet (23. mars 2021).
Overvåking av HPV i Meldingssystemet for smittsomme sykdommer (MSIS). [nettdokument]. Oslo: Folkehelseinstituttet. Hentet 23. september 2025 fra
https://www.fhi.no/hn/helseregistre-og-registre/msis/msis-biobank/hpv-i-msis/
Folkehelseinstituttet (13. mars 2025).
Anbefalt vaksinasjonsregime. I: Vaksinasjonshåndboka: HPV-vaksine (Humant papillomavirus) – håndbok for helsepersonell. [nettdokument]. Oslo: Folkehelseinstituttet. Hentet 24. september 2025 fra
https://www.fhi.no/va/vaksinasjonshandboka/vaksiner-mot-de-enkelte-sykdommene/hpv-vaksinasjon/?term=#anbefalt-vaksinasjonsregime
Folkehelseinstituttet (06. mai 2025).
8. Klassifikasjon cytologi, histologi og HPV-tester. I: Kvalitetsmanual for Livmorhalsprogrammet. [nettdokument]. Oslo: Folkehelseinstiututtet. Hentet 01. desember 2025 fra
https://www.fhi.no/kreft/kreftscreening/livmorhalsprogrammet/helsepersonell/kvalitetsmanual/kapitler/82.-klassifikasjon-cytologi-histologi-og-hpv-tester
IARC, (2022).
Cervical cancer screening. Volume 18. Lyon: IARC. Hentet IARC Handbooks of Cancer Prevention fra
https://publications.iarc.who.int/Book-And-Report-Series/Iarc-Handbooks-Of-Cancer-Prevention/Cervical-Cancer-Screening-2022
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, (2012).
Human Papillomaviruses. I: Biological agents: a review of human carcinogens. Lyon: IARC. Hentet IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 100 B. s. 255-313 fra
https://monographs.iarc.fr/wp-content/uploads/2018/06/mono100B-11.pdf
Kreftregisteret, (2024).
Kreftregisterets årsrapport 2023. Oslo: Kreftregisteret. Hentet fra
https://www.fhi.no/globalassets/publikasjoner-og-rapporter/arsrapporter/publisert-2024/arsrapport-kreftregisteret-2023.pdf
Larsen, I.K. (2011).
Cancer in Norway 2009: cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway.
Nayar, R., & Wilbur, D. C. (2015).
The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. Springer.
Regionala cancersentrum i samverkan, (25. juni 2024).
Nationellt vårdprogram livmoderhals- och vaginalcancer. Version 2.2. [nettdokument]. Stockholm: RCC. Hentet 24. september 2025 fra
https://kunskapsbanken.cancercentrum.se/diagnoser/livmoderhals-och-vaginalcancer/vardprogram/
Schmucker, C., Kapp, P., Brugger, T., Gorenflo, L., Thörel, E., Siemens, W., Röbl-Mathieu, M., Askar, M., Harder, T., Meerpohl, J. J., EU/EEA NITAG Collaboration HPV Working Group and ECDC representatives, (2024).
Efficacy, effectiveness and safety of HPV vaccination in women with conisation: a systematic review and meta-analyses. Stockholm: ECDC.
Shafi, M. (2007).
European Quality Standards for the Treatment of Cervical Intraepithelial Neoplasia (CIN) 2007. [nettdokument]. Brussel: European Federation For Colposcopy. Hentet 24. september 2025 fra
https://efcolposcopy.eu/european-quality-standards-for-the-treatment-of-cervical-intraepithelial-neoplasia-cin-2007/
Alfonzo, E., Zhang, C., Daneshpip, F., & Strander, B. (2023). Accuracy of colposcopy in the Swedish screening program.
Acta Obstetricia et Gynecologica Scandinavica,
102(5), 549-555.
Baasland, I., Hagen, B., Vogt, C., Valla, M., & Romundstad, P. R. (2016). Colposcopy and additive diagnostic value of biopsies from colposcopy-negative areas to detect cervical dysplasia.
Acta Obstetricia et Gynecologica Scandinavica,
95(11), 1258-1263.
Hagen, B., Skjeldestad, F. E., Bratt, H., Tingulstad, S., & Lie, A. K. (1998). CO2 laser conization for cervical intraepithelial neoplasia grade II-III: complications and efficacy.
Acta Obstetricia et Gynecologica Scandinavica,
77(5), 558-63.
Nøhr, B., Tabor, A., Frederiksen, K., & Kjær, S. K. (2007). Loop electrosurgical excision of the cervix and the subsequent risk of preterm delivery.
Acta Obstetricia et Gynecologica Scandinavica,
86(5), 596-603.
Sjøborg, K. D., Vistad, I., Myhr, S. S., Svenningsen, R., Herzog, C., Kloster-Jensen, A., ... Tanbo, T. (2007). Pregnancy outcome after cervical cone excision: a case-control study.
Acta Obstetricia et Gynecologica Scandinavica,
86(4), 423-8.
Guido, R., Schiffman, M., Solomon, D., Burke, L., & ASCUS LSIL Triage Study (ALTS) Group, (2003). Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.
American Journal of Obstetrics and Gynecology,
188(6), 1401-5.
Hunter, M. I., Monk, B. J., & Tewari, K. S. (2008). Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease.
American Journal of Obstetrics and Gynecology,
199(1), 3-9.
Tierney, K. E., Lin, P. S., Amezcua, C., Matsuo, K., Ye, W., Felix, J. C., & Roman, L. D. (2014). Cervical conization of adenocarcinoma in situ: a predicting model of residual disease.
American Journal of Obstetrics and Gynecology,
210(4), 366.e1-366.e5.
Madeleine, M. M., Finch, J. L., Lynch, C. F., Goodman, M. T., & Engels, E. A. (2013). HPV-related cancers after solid organ transplantation in the United States.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
13(12), 3202-9.
Ghaem-Maghami, S., & Soutter, W. P. (2009). Re: Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years.
BJOG: An International Journal of Obstetrics and Gynaecology,
116(3), 465.
Bowden, S. J., Doulgeraki, T., Bouras, E., Markozannes, G., Athanasiou, A., Grout-Smith, H., ... Kyrgiou, M. (2023). Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies.
BMC Medicine,
21(1), 274.
Albrechtsen, S., Rasmussen, S., Thoresen, S., Irgens, L. M., & Iversen, O. E. (2008). Pregnancy outcome in women before and after cervical conisation: population based cohort study.
BMJ,
337, a1343.
Kyrgiou, M., Athanasiou, A., Paraskevaidi, M., Mitra, A., Kalliala, I., Martin-Hirsch, P., ... Paraskevaidis, E. (2016). Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis.
BMJ,
354, i3633.
Strander, B., Hallgren, J., & Sparen, P. (2014). Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality.
BMJ,
348, f7361.
Tainio, K., Athanasiou, A., Tikkinen, K. A. O., Aaltonen, R., Cárdenas, J., Hernándes,, ... Kalliala, I. (2018). Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.
BMJ,
360, k499.
Castanon, A., Brocklehurst, P., Evans, H., Peebles, D., Singh, N., Walker, P., ... Sasieni, P. (2012). Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study.
BMJ (Clinical research ed.),
345, e5174.
Castanon, A., Landy, R., Brocklehurst, P., Evans, H., Peebles, D., Singh, N., ... Sasieni, P. (2014). Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study.
BMJ (Clinical research ed.),
349, g6223.
Falcaro, M., Soldan, K., Ndlela, B., & Sasieni, P. (2024). Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
BMJ (Clinical research ed.),
385, e077341.
Palmer, T., Wallace, L., Pollock, K. G., Cuschieri, K., Robertson, C., Kavanagh, K., & Cruickshank, M. (2019). Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study.
BMJ (Clinical research ed.),
365, l1161.
Kjellberg, L., Hallmans, G., Ahren, A. M., Johansson, R., Bergman, F., Wadell, G., ... Dillner, J. (2000). Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection.
British Journal of Cancer,
82(7), 1332-8.
Portnoy, A., Pedersen, K., Kim, J. J., & Burger, E. A. (2024). Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis.
British Journal of Cancer,
130(12), 1951-1959.
Iacobone, A. D., Radice, D., Sandri, M. T., Preti, E. P., Guerrieri, M. E., Vidal Urbinati, A. M., ... Bottari, F. (2021). Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence.
Cancers,
13(15)
Joura, E. A., Kyrgiou, M., Bosch, F. X., Kesic, V., Niemenen, P., Redman, C. W., & Gultekin, M. (2019). Human papillomavirus vaccination: The ESGO-EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy.
European Journal of Cancer,
116, 21-26.
McGee, A. E., Alibegashvili, T., Elfgren, K., Frey, B., Grigore, M., Heinonen, A., ... Cruickshank, M. E. (2023). European consensus statement on expert colposcopy.
European Journal of Obstetrics, Gynecology, and Reproductive Biology,
290, 27-37.
de Araujo Souza, P. S., Sichero, L., & Maciag, P. C. (2009). HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer.
5(3), 359-70.
Bogani, G., D. I. Donato V, Sopracordevole, F., Ciavattini, A., Ghelardi, A., Lopez, S., ... Raspagliesi, F. (2020). Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
Gynecologic Oncology,
159(3), 636-641.
Munro, A., Leung, Y., Spilsbury, K., Stewart, C. J., Semmens, J., Codde, J., ... Cohen, P. (2015). Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?.
Gynecologic Oncology,
137(2), 258-63.
Stanley, M. (2010). Pathology and epidemiology of HPV infection in females.
Gynecologic Oncology,
117(2 Suppl), S5-10.
Gadducci, A., Barsotti, C., Cosio, S., Domenici, L., & Riccardo Genazzani, A. (2011). Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature.
Gynecological Endocrinology,
27(8), 597-604.
Tropé, C. (2014). En forenklet kolposkopiguide.
Gynekologen,
27(2), 35-40.
Kjaer, S. K., Nygård, M., Sundström, K., Munk, C., Berger, S., Dzabic, M., ... Luxembourg, A. (2021). Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-up.
Human Vaccines & Immunotherapeutics,
17(4), 943-949.
Plotzker, R. E., Vaidya, A., Pokharel, U., & Stier, E. A. (2023). Sexually Transmitted Human Papillomavirus: Update in Epidemiology, Prevention, and Management.
Infectious Disease Clinics of North America,
37(2), 289-310.
Combes, J. D., Pawlita, M., Waterboer, T., Hammouda, D., Rajkumar, T., Vanhems, P., ... Clifford, G. (2014). Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
International Journal of Cancer,
135(10), 2453-61.
Silins, I., Ryd, W., Strand, A., Wadell, G., Tornberg, S., Hansson, B. G., ... Rylander, E. (2005). Chlamydia trachomatis infection and persistence of human papillomavirus.
International Journal of Cancer,
116(1), 110-5.
Tjalma, W. A., Fiander, A., Reich, O., Powell, N., Nowakowski, A. M., Kirschner, B., ... Holl, K. (2013). Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
International Journal of Cancer,
132(4), 854-67.
Vaccarella, S., Herrero, R., Snijders, P. J., Dai, M., Thomas, J. O., Hieu, N. T., ... Franceschi, S. (2008). Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.
International Journal of Epidemiology,
37(3), 536-46.
Baalbergen, A., & Helmerhorst, T. J. (2014). Adenocarcinoma in situ of the uterine cervix--a systematic review.
International Journal of Gynecological Cancer,
24(9), 1543-8.
Sadler, L., Saftlas, A., Wang, W., Exeter, M., Whittaker, J., & McCowan, L. (2004). Treatment for cervical intraepithelial neoplasia and risk of preterm delivery.
JAMA,
291(17), 2100-6.
Castle, P. E., Schiffman, M., Herrero, R., Hildesheim, A., Rodriguez, A. C., Bratti, M. C., ... Burk, R. D. (2005). A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
Journal of Infectious Diseases,
191(11), 1808-16.
Dillner, J., Kallings, I., Brihmer, C., Sikström, B., Koskela, P., Lehtinen, M., ... Mardh, P. A. (1996). Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior.
Journal of Infectious Diseases,
173(6), 1394-8.
Sundström, K., & Dillner, J. (2021). How Many Human Papillomavirus Types Do We Need to Screen For?.
The Journal of infectious diseases,
223(9), 1510-1511.
Bowring, J., Strander, B., Young, M., Evans, H., & Walker, P. (2010). The Swede score: evaluation of a scoring system designed to improve the predictive value of colposcopy.
Journal of Lower Genital Tract Disease,
14(4), 301-5.
Li, Z., & Zhao, C. (2013). Long-term follow-up results from women with cervical adenocarcinoma in situ treated by conization: an experience from a large academic women's hospital.
Journal of Lower Genital Tract Disease,
17(4), 452-8.
Moscicki, A. B., Flowers, L., Huchko, M. J., Long, M. E., MacLaughlin, K. L., Murphy, J., ... Gold, M. A. (2019). Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Journal of Lower Genital Tract Disease,
23(2), 87-101.
Pretorius, R. G., Belinson, J. L., Burchette, R. J., Hu, S., Zhang, X., & Qiao, Y. L. (2011). Regardless of skill, performing more biopsies increases the sensitivity of colposcopy.
Journal of Lower Genital Tract Disease,
15(3), 180-8.
Siegler, E., Amit, A., Lavie, O., Auslender, R., Mackuli, L., & Weissman, A. (2014). Cervical intraepithelial neoplasia 2, 3 in pregnancy: time to consider loop cone excision in the first trimester of pregnancy?.
Journal of Lower Genital Tract Disease,
18(2), 162-8.
Wright, T. C., Jr., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007). 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.
Journal of Lower Genital Tract Disease,
11(4), 223-39.
Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., ... Munoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Journal of Pathology,
189(1), 12-9.
Palmer, T. J., Kavanagh, K., Cuschieri, K., Cameron, R., Graham, C., Wilson, A., & Roy, K. (2024). Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
Journal of the National Cancer Institute,
116(6), 857-865.
Huh, W. K., Joura, E. A., Giuliano, A. R., Iversen, O. E., de Andrade, R. P., Ault, K. A., ... Luxembourg, A. (2017). Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Lancet,
390(10108), 2143-2159.
Kyrgiou, M., Koliopoulos, G., Martin-Hirsch, P., Arbyn, M., Prendiville, W., & Paraskevaidis, E. (2006). Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis.
Lancet,
367(9509), 489-98.
Arbyn, M., Redman, C. W. E., Verdoodt, F., Kyrgiou, M., Tzafetas, M., Ghaem-Maghami, S., ... Moss, E. L. (2017). Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis.
Lancet Oncology,
18(12), 1665-1679.
Kocken, M., Helmerhorst, T. J., Berkhof, J., Louwers, J. A., Nobbenhuis, M. A., Bais, A. G., ... Meijer, C. J. (2011). Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
Lancet Oncology,
12(5), 441-50.
Lehtinen, M., Paavonen, J., Wheeler, C. M., Jaisamrarn, U., Garland, S. M., Castellsagué, X., ... Dubin, G. (2012). Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Lancet Oncology,
13(1), 89-99.
McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. (2008). Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.
Lancet Oncology,
9(5), 425-34.
Middeldorp, M., Brouwer, J. G. M., Duijster, J. W., Knol, M. J., van Kemenade, F. J., Siebers, A. G., ... de Melker, H. E. (2025). The effect of bivalent HPV vaccination against invasive cervical cancer and CIN3+ in the Netherlands: a national linkage study.
medRxiv : the preprint server for health sciences
Joura, E. A., Giuliano, A. R., Iversen, O. E., Bouchard, C., Mao, C., Mehlsen, J., ... Luxembourg, A. (2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
The New England journal of medicine,
372(8), 711-23.
Muñoz, N., Bosch, F. X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K. V., ... International Agency for Research on Cancer Multicenter Cervical Cancer Study Group, (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer.
New England Journal of Medicine,
348(6), 518-27.
Bjørge, T., Skare, G. B., Bjørge, L., Tropé, A., & Lönnberg, S. (2016). Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia.
Obstetrics and Gynecology,
128(6), 1265-1273.
Castle, P. E., Gage, J. C., Wheeler, C. M., & Schiffman, M. (2011). The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.
Obstetrics and Gynecology,
118(6), 1222-1229.
Castle, P. E., Schiffman, M., Wheeler, C. M., & Solomon, D. (2009). Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2.
Obstetrics and Gynecology,
113(1), 18-25.
Gage, J. C., Hanson, V. W., Abbey, K., Dippery, S., Gardner, S., Kubota, J., ... Jeronimo, J. (2006). Number of cervical biopsies and sensitivity of colposcopy.
Obstetrics and Gynecology,
108(2), 264-72.
Paraskevaidis, E., Jandial, L., Mann, E. M., Fisher, P. M., & Kitchener, H. C. (1991). Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol.
Obstetrics and Gynecology,
78(1), 80-3.
Schiffman, M., & Wentzensen, N. (2010). From human papillomavirus to cervical cancer.
Obstetrics and Gynecology,
116(1), 177-85.
Tatti, S., Bornstein, J., & Prendiville, W. (2013). Colposcopy: a global perspective: introduction of the new IFCPC colposcopy terminology.
Obstetrics and Gynecology Clinics of North America,
40(2), 235-50.
Rykkelid, M., Wennberg, H. M., Richardsen, E., & Sørbye, S. W. (2024). Post-Conization HPV Vaccination and Its Impact on Viral Status: A Retrospective Cohort Study in Troms and Finnmark, 2022.
Pathogens,
13(5)
Leo, P. J., Madeleine, M. M., Wang, S., Schwartz, S. M., Newell, F., Pettersson-Kymmer, U., ... Brown, M. A. (2017). Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.
PLoS Genet,
13(8), e1006866.
Baasland, I., Bjørge, T., Engesæter, B., Tropé, A., & Opdahl, S. (2025). Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment.
PloS One,
20(4), e0320739.
Bruni, L., Saura-Lázaro, A., Montoliu, A., Brotons, M., Alemany, L., Diallo, M. S., ... Bloem, P. (2021). HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019.
Preventive Medicine,
144, 106399.
Ueda, Y., Enomoto, T., Miyatake, T., Yoshino, K., Fujita, M., Miyake, T., ... Kimura, T. (2009). Postpartum outcome of cervical intraepithelial neoplasia in pregnant women determined by route of delivery.
Reproductive Sciences,
16(11), 1034-9.
Doorbar, J. (2023). The human Papillomavirus twilight zone - Latency, immune control and subclinical infection.
Tumour virus research,
16, 200268.
Bosch, F. X., Broker, T. R., Forman, D., Moscicki, A. B., Gillison, M. L., Doorbar, J., ... de Sanjose, S. (2013). Comprehensive control of human papillomavirus infections and related diseases.
Vaccine,
31 Suppl 7, H1-31.
Dillner, J., Nygård, M., Munk, C., Hortlund, M., Hansen, B. T., Lagheden, C., ... Kjaer, S. K. (2018). Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
Vaccine,
36(26), 3820-3829.
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., ... Franceschi, S. (2012). Global burden of human papillomavirus and related diseases.
Vaccine,
30 Suppl 5, F12-23.
Mikalsen, M. P., Simonsen, G. S., & Sørbye, S. W. (2024). Impact of HPV Vaccination on the Incidence of High-Grade Cervical Intraepithelial Neoplasia (CIN2+) in Women Aged 20-25 in the Northern Part of Norway: A 15-Year Study.
Vaccines,
12(4)
Gravitt, P. E., & Winer, R. L. (2017). Natural History of HPV Infection across the Lifespan: Role of Viral Latency.
Viruses,
9(10)
- Gå til avsnitt
- Swede kolposkopi score
- Referanser
Lukk
Kopiert
